Moneycontrol PRO
HomeNewsVaccination drive

Vaccination Drive

Jump to
  • Vaccination drive became a people's movement: PM Modi talks about rush to provide vaccine to everyone

    "A lot of strength went into this project. Several government projects were sidelined to give priority to this task," said PM Modi in 'The Vial-India’s Vaccine Story’ --- History TV18’s new documentary on the country’s Covid-19 vaccine journey

  • India all set to start administering booster dose of COVID-19 vaccine from today

    CoWIN will send reminder messages to all those eligible for this dose and after administration of the shot, it will be noted in the digital vaccination certificate. Online appointments for precaution dose began on the CoWin portal on Saturday evening.

  • From Delhi to Odisha, these states have ordered schools to remain shut as COVID-19 cases spike

    Even though the vaccination drive for 15-18 year olds has begun today, many states have instructed schools to opt for online classes.

  • Vaccination in Himalayas: Doctors scale rockslides, invoke gods

    Despite the hostile terrain, the northern state of Himachal Pradesh, where Malana is located, earlier this month became the first in India to administer at least one COVID-19 vaccine dose in all its adults.

  • BJP chief JP Nadda slams Opposition for 'baseless allegations' on vaccination drive

    JP Nadda praised the leadership of Prime Minister Narendra Modi at the Centre and Chief Minister Yogi Adityanath's in the state in tackling the pandemic.

  • Infosys vaccinates half the workforce, up to 30% may return to office within six months

    The Bengaluru-based IT major has vaccinated 58 percent of employees with first dose and 10 percent with both the doses. It has also placed an order for 25 lakh doses to vaccinate its employees.

  • India vaccination drive hits record high with around 4 crore jabs this week

    Out of the 3.98 crore jabs given this week, nearly 70 percent of the vaccinations (2.74 crore) were received in the 18-44 age group.

  • COVID-19 | Vaccine hesitancy puts India's gains against virus at risk

    There is still widespread hesitancy fueled by misinformation and mistrust, particularly in rural areas where two-thirds of the country’s nearly 1.4 billion population lives. Health workers face stiff resistance from people who believe that vaccines cause impotence, serious side effects and could even kill. Some simply say they do not need the shots because they're immune to the coronavirus.

  • Reliance Industries launches India’s largest private COVID vaccination drive; to give free jabs to over 1.3 million employees, their families

    RIL's vaccination drive is expected to reduce the burden of India's public healthcare institutions.

  • TCS to set up 100 COVID-19 vaccination centres for employees across India

    Peers Infosys, Wipro, and HCL Tech have also started vaccination drive for their employees. The top four IT firms employ over 10 lakh people and will be covering the cost of vaccination for all their employees.

  • Herd Immunity Part 2: Is the race a sprint or a marathon?

    In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.

  • Herd Immunity Part 1: Why the markets are not feeling the pain of the second wave

    With markets making a wild swing from despondency to euphoria last year, investors do not want to miss a recovery rally this time around and are exercising patience in the hope of a better second half

  • Companies seek government clarity on vaccination and more doses; say it is important for restoring normalcy

    HCL Tech needs 6 lakh doses, both for employees and the vendors it is looking to vaccinate in the country, but have got a commitment for a few thousand doses in NCR and Chennai, making the supply and demand gap rather substantial.

  • You now have to enter a Captcha while booking your vaccination

    The move aims to prevent techies from cornering vaccine slots, but has made the booking process cumbersome

  • Sensex dives 983 points on Day 1 of May series: Time to turn cautious or stay put?

    The Nifty has to cross 14,700 to witness an upmove towards 14,900 and 15,050, while on the downside, support exists at 14,400 and 14,250 zones, say experts.

  • Procter & Gamble pledges Rs 50 crore for vaccination of over 5 lakh citizens

    The company will also cover vaccination costs of its employees and their eligible family members.

  • Wipro to organise vaccination camps for employees in Bengaluru, other parts of India

    Wipro employs about 1.9 lakh people. The company also plans to facilitate complimentary pre- and post-vaccination support as well as vaccination reimbursement for its employees and their spouses.

  • COVID-19 spike | IT majors get ready to vaccinate staff; Infosys partners with 130 hospitals in India, in talks with suppliers

    Infosys has also established vaccination centres for its employees and their families at some of the campuses across India, and is in the process of extending them.

  • Everyone above 45 can now get COVID-19 vaccine, here is all you need to know

    The beneficiaries can book appointments through the Co-WIN portal or can walk into a vaccination centre for the jab.

  • COVID-19 | Tech glitches mar vaccination drive in India

    However, experts Moneycontrol spoke to described these as teething issues which will be ironed out in the coming days.

  • Budget 2021: Vaccine allocation of Rs 35,000 crore to immunise 50 crore people

    Expenditure Secretary TV Somanathan told Moneycontrol that the Finance Ministry had a rough cost of Rs 700 per person in mind. The budget allocation is just a part of what will be spent, as state governments and corporates will also allocate sums for the vaccination drive

  • India drug monitoring programme struggles to grow fast enough

    To make a new drug in India, companies need permission from the national drug controller after submitting safety and efficacy data including from local clinical trials. For four years after an approved drug is on the market, firms must submit safety reports, including those on adverse drug reactions.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347